on Aquis Stock Exchange
Aquis Stock Exchange: Trading Suspension Notice
On October 10, 2024, trading was suspended on the Aquis Growth Market for Mydecine Innovations Group Inc. This action was due to non-payment of exchange fees, in accordance with Rule 3.10 of the Aquis Stock Exchange Rulebook. The suspension affects the ordinary shares of the group.
The situation highlights the importance of compliance with trading rules and fee payments for companies listed on the exchange. The role of the Regulation Department at Aquis Stock Exchange is critical in enforcing these regulations to ensure market integrity.
The Aquis Stock Exchange continues to uphold its regulatory standards, emphasizing the need for all listed companies to adhere strictly to rules to avoid trading interruptions.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Aquis Stock Exchange news